Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction

MLA

Mann, Douglas L., et al. “Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction.” JACC: Heart Failure, vol. 8, no. 10, Oct. 2020, pp. 789–99. EBSCOhost, https://doi.org/10.1016/j.jchf.2020.05.005.

APA

Mann, D. L., Greene, S. J., Givertz, M. M., Vader, J. M., Starling, R. C., Ambrosy, A. P., Shah, P., McNulty, S. E., Mahr, C., Gupta, D., Redfield, M. M., Lala, A., Lewis, G. D., Mohammed, S. F., Gilotra, N. A., DeVore, A. D., Gorodeski, E. Z., Desvigne-Nickens, P., Hernandez, A. F., & Braunwald, E. (2020). Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction. JACC: Heart Failure, 8(10), 789–799. https://doi.org/10.1016/j.jchf.2020.05.005

Chicago

Mann, Douglas L., Stephen J. Greene, Michael M. Givertz, Justin M. Vader, Randall C. Starling, Andrew P. Ambrosy, Palak Shah, et al. 2020. “Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction.” JACC: Heart Failure 8 (10): 789–99. doi:10.1016/j.jchf.2020.05.005.